Table 1. Characteristics of Breast Carcinoma.
ER: estrogen receptor; Her-2/neu: human epidermal growth factor receptor 2; PR: progesterone receptor
| Breast carcinoma characteristics | Frequency | Percentage |
| Side involved | ||
| Left | 27 | 54.00% |
| Right | 23 | 46.00% |
| Vitamin D levels(ng/mL) | ||
| <30 (deficient) | 43 | 86.00% |
| >30 (sufficient) | 7 | 14.00% |
| Tumor differentiation | ||
| Poorly differentiated | 20 | 40.00% |
| Moderately differentiated | 19 | 38.00% |
| Well-differentiated | 11 | 22.00% |
| ER, PR, and Her-2/neu status | ||
| ER status | ||
| Negative | 25 | 50.00% |
| Positive | 25 | 50.00% |
| PR status | ||
| Negative | 27 | 54.00% |
| Positive | 23 | 46.00% |
| Her-2/neu status | ||
| Negative | 24 | 48.00% |
| Positive | 26 | 52.00% |
| Luminal status | ||
| Her-2/neu amplified | 14 | 28.00% |
| Luminal A | 13 | 26.00% |
| Luminal B | 12 | 24.00% |
| TNBC | 11 | 22.00% |